• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553550
Device Problems Activation, Positioning or Separation Problem (2906); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/14/2022
Event Type  malfunction  
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that a hot axios stent was to be implanted transgastric to the pancreas to treat a pancreatic pseudocyst during an endoscopic ultrasound (eus)- cystogastrostomy procedure performed on (b)(6).2022.During the procedure, the second flange did not deploy.The physician also noted that the first flange did not fully expand.The stent was removed partially deployed and a different device was used to complete the procedure.There were no patient complications due to this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Initial reporter address:(b)(6).(b)(4).The device has not been received for analysis.Upon receipt and completion of the problem analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Manufacturer Narrative
Block b5 has been updated with the additional information received on november 09, 2022.Block e1: initial reporter address: chandigarh rd, near civil hospital, phase 6, sec-56, sas nagar.Block h6: medical device problem code a150101 captures the reportable event of stent first flange failed to expand.Medical device problem code a15 captures the reportable event of stent partially deployed.Block h10 the device has not been received for analysis.Upon receipt and completion of the problem analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022, that a hot axios stent was to be implanted transgastric to the pancreas to treat a pancreatic pseudocyst during an endoscopic ultrasound (eus)- cystogastrostomy procedure performed on (b)(6) 2022.During the procedure, the second flange did not deploy.The physician also noted that the first flange did not fully expand.The stent was removed partially deployed and a different device was used to complete the procedure.There were no patient complications due to this event.The patient's condition at the conclusion of the procedure was reported to be stable.Additional information received on november 09, 2022: it was reported that the physician did not attempt to re-constrain the stent.
 
Manufacturer Narrative
Block b5 :has been updated with the additional information received on november 09, 2022.Block e1: initial reporter address: chandigarh rd, near civil hospital, phase 6, sec-56, sas nagar.Block h6: medical device problem code a150101 captures the reportable event of stent first flange failed to expand.Medical device problem code a15 captures the reportable event of stent partially deployed.Block h10: an axios stent and electrocautery enhanced delivery system were returned for analysis.The stent was returned partially deployed.Visual examination of the returned device found one wire of the stent broken and holes were noted on the stent cover.The inner tube was also kinked.Functional inspection was performed, the stent was able to be deployed; however, resistance was felt and the proximal flange did not expand.No other problems were noted to the stent and delivery system.The investigation concluded that the observed failure of stent partially deployed and inner tube kinked were likely due to factors encountered during the procedure.It may be that lesion characteristics, how the device was handled, the technique used by the physician and/or normal procedural difficulties encountered during the procedure, limited the performance of the device and contributed to the stent partial deployment and inner tube kinked.The reported event of stent first flange failure to expand cannot be confirmed; the stent first flange was received fully expanded.Taking all available information into consideration, investigation findings do not lead to a clear conclusion about the cause of the reported events.Therefore, a review and analysis of all available information indicated the most probable cause is cause not established.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.
 
Event Description
It was reported to boston scientific corporation on april 14, 2022, that a hot axios stent was to be implanted transgastric to the pancreas to treat a pancreatic pseudocyst during an endoscopic ultrasound (eus)- cystogastrostomy procedure performed on (b)(6) 2022.During the procedure, the second flange did not deploy.The physician also noted that the first flange did not fully expand.The stent was removed partially deployed and a different device was used to complete the procedure.There were no patient complications due to this event.The patient's condition at the conclusion of the procedure was reported to be stable.Additional information received on november 09, 2022.It was reported that the physician did not attempt to re-constrain the stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14291431
MDR Text Key293485334
Report Number3005099803-2022-02335
Device Sequence Number1
Product Code PCU
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K150692
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/18/2024
Device Model NumberM00553550
Device Catalogue Number5355
Device Lot Number0028698862
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/14/2022
Initial Date FDA Received05/05/2022
Supplement Dates Manufacturer Received11/09/2022
12/13/2022
Supplement Dates FDA Received12/01/2022
01/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age45 YR
Patient SexMale
Patient Weight78 KG
-
-